1432045-89-0Relevant academic research and scientific papers
Discovery of novel orally bioavailable GPR40 agonists
Lu, Hejun,Fei, Hongbo,Yang, Fanglong,Zheng, Suxin,Hu, Qiyue,Zhang, Lei,Yuan, Jijun,Feng, Jun,Sun, Piaoyang,Dong, Qing
, p. 2920 - 2924 (2013/06/27)
The GPR40 (FFA1) has emerged as an attractive target for a novel insulin secretagogue with glucose dependency. A series of novel orally bioavailable GPR40 agonists was discovered. SAR study and structural optimization led to identification of compounds 28a and 30a as potent GPR40 agonists with superior physiochemical properties and robust in vivo efficacy in rhesus monkeys.
